AVAGARD CHG 61 %
ALCOHOL ANHYDROUS : 61 % CHLORHEXIDINE GLUCONATE : 1 % · DIN 02246888 · 3M HEALTHCARE CANADA COMPANY LIMITED
Health Canada status: MARKETED
What is AVAGARD CHG?
AVAGARD CHG 61 % contains ALCOHOL ANHYDROUS : 61 % CHLORHEXIDINE GLUCONATE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02246888, held by 3M HEALTHCARE CANADA COMPANY LIMITED, supplied as LOTION for TOPICAL (HOSPITAL/HC FACILITIES) administration. Health Canada currently lists it as marketed, status dated 03-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02246888 |
|---|---|
| Brand name | AVAGARD CHG |
| Generic / active ingredient | ALCOHOL ANHYDROUS : 61 % CHLORHEXIDINE GLUCONATE : 1 % |
| Manufacturer | 3M HEALTHCARE CANADA COMPANY LIMITED |
| Strength | 61 % |
| Dosage form | LOTION |
| Route of administration | TOPICAL (HOSPITAL/HC FACILITIES) |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D08AC52 CHLORHEXIDINE, COMBINATIONS |
| AHFS class | 84:04.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 03-Mar-2026 |
| Original market date | 2003-07-02 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D08AC52 CHLORHEXIDINE, COMBINATIONS. 12 of 49 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BAXEDIN 2% - 70% | 70 % | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02251477 |
| CHLORAPREP | 70 % | SOLUTION | BECTON DICKINSON CANADA INC. | MARKETED | DIN 02484374 |
| CHLORAPREP SWABSTICKS | 2 % | SWAB | BECTON DICKINSON CANADA INC. | MARKETED | DIN 02525585 |
| DEXIDIN 0.5 SOLUTION | 70.0 % | LIQUID | LABORATOIRE ATLAS INC | MARKETED | DIN 02240680 |
| SOLUPREP APPLICATOR | 70 % | SOLUTION | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02382113 |
| SOLUPREP QD SWAB | 70 % | SWAB | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02119803 |
| SOLUPREP QD WIPE | 0.5 % | WIPE | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02060019 |
| SOLUPREP SWAB | 2 % | SWAB | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02382040 |
| SOLUPREP WIPE | 70 % | WIPE | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02385708 |
| STANHEXIDINE 2% WITH ISOPROPYL ALCOHOL 4% | 4 % | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 01938991 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.